BlueClinical, an Astrum company in Portugal, is proud to share that we have been recognized once again by the Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research.

The renewal of this 8-year certification not only underscores our continued dedication to innovation, but allows us to strengthen our support in bringing scientific innovation to patients. This is achieved through our continued provision of significant financial and fiscal benefits to our Pharma, Biotech, and Medtech clients.

At Astrum, our companies continue to be validated for our professional, innovative, and conscientious approach. With each of these milestones we are increasingly motivated to deliver exceptional client and patient care.